Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F7UW3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,973
Award facts
- Contract value 100% obligated
- $6,973.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on January 5, 2026, with a ceiling value of $6,973.34 and ultimate completion date of January 27, 2026. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and other autoimmune conditions, reflecting the Defense Logistics Agency's responsibility for providing critical pharmaceuticals to support military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 through December 2026. The prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply an extensive range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism, demonstrating the company's established capability to meet federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F7UW3?
SPE2DR26F7UW3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F7UW3 worth?
The government has obligated $6,973 on SPE2DR26F7UW3.
Is contract SPE2DR26F7UW3 an order under another contract?
Yes. SPE2DR26F7UW3 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UW3 competed?
The extent of competition for SPE2DR26F7UW3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award